Your session is about to expire
← Back to Search
TXTXT Intervention for HIV Adherence
Study Summary
This trial will evaluate if TXTXT intervention can help improve adherence & viral load suppression in young people living with HIV.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 16 and 35 years old.I have been on HIV treatment for at least one month.I am not between the ages of 16 and 35.I am unable to understand and give consent for treatment.
- Group 1: Intervention
- Group 2: Comparison
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Could you inform me of the various venues in which this research is being conducted within the state?
"In addition to Howard Brown Health in Chicago, IL and Eskenazi Health in Indianapolis, IN, this trial is also occurring out of Indiana University in Lake Charles, LA. There are 11 other sites that have been approved for study participation."
Does this clinical trial stipulate a minimum age requirement?
"To be considered for this medical trial, patients must be aged between 16 and 35. Conversely, there are 109 studies recruiting individuals younger than that age bracket and 340 trials targeting seniors 65 years old or older."
How many participants are being admitted into this experiment?
"This clinical trial calls for 600 participants with the required qualifications. Patients can be enlisted from several locations, including Howard Brown Health in Chicago and Eskenazi Health near Indianapolis."
Are there openings available to join this research project now?
"Affirmative. Clinicaltrials.gov data demonstrates that this clinical trial, which was initially announced April 17th 2023, is actively searching for participants. 600 individuals need to be enrolled from 11 different medical centres."
Could I qualify to participate in this trial?
"This clinical study is recruiting 600 individuals that meet the following criteria: Infected with HIV, aged between 16-35 years old, currently medicated and able to report a viral load of ≥200c/mL or demonstrate poor adherence (<90% of pills taken in the last 30 days), capable of receiving text messages, and willing to participate after providing informed consent."
Share this study with friends
Copy Link
Messenger